Figure 6
Figure 6. Knockdown or inhibition of HDAC6 augments loss of clonogenic survival due to treatment with 17-AAG. (A) K562-transfected with control/siHDAC6 construct for 24 hours followed by treatment with indicated doses of 17-AAG for 24 hours and colonies were counted on day 10. Values plotted are means of 3 experiments plus or minus SD. P values were determined by Student t test. (B) K562-transfected with control/siHDAC6 construct for 48 hours, stained with anti-HDAC6 and anti–Ki-67 antibodies, and imaged using confocal immunofluorescent microscope using a 63×/1.2 W correction objective. (C) K562 cells were treated with indicated doses of tubacin with or without 17-AAG for 48 hours, and the loss of survival was assessed by trypan blue exclusion test. Error bars represent SD.

Knockdown or inhibition of HDAC6 augments loss of clonogenic survival due to treatment with 17-AAG. (A) K562-transfected with control/siHDAC6 construct for 24 hours followed by treatment with indicated doses of 17-AAG for 24 hours and colonies were counted on day 10. Values plotted are means of 3 experiments plus or minus SD. P values were determined by Student t test. (B) K562-transfected with control/siHDAC6 construct for 48 hours, stained with anti-HDAC6 and anti–Ki-67 antibodies, and imaged using confocal immunofluorescent microscope using a 63×/1.2 W correction objective. (C) K562 cells were treated with indicated doses of tubacin with or without 17-AAG for 48 hours, and the loss of survival was assessed by trypan blue exclusion test. Error bars represent SD.

Close Modal

or Create an Account

Close Modal
Close Modal